Boston Scientific Corporation
NYSE:BSX
Sector
Location
Market Cap
USD 152.25 B
Share Price
USD 102.75
Avg Daily Volume
7,504,720
Change (1 day)
-0.38%
Change (1 year)
34.86%
Change (YTD)
15.04%
Boston Scientific Corporation Accounts Payable for the year ending December 31, 2024: USD 960.00 M
Boston Scientific Corporation Accounts Payable is USD 960.00 M for the year ending December 31, 2024, a 1.91% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Boston Scientific Corporation Accounts Payable for the year ending December 31, 2023 was USD 942.00 M, a 9.28% change year over year.
-
Boston Scientific Corporation Accounts Payable for the year ending December 31, 2022 was USD 862.00 M, a 8.56% change year over year.
-
Boston Scientific Corporation Accounts Payable for the year ending December 31, 2021 was USD 794.00 M, a 54.78% change year over year.
-
Boston Scientific Corporation Accounts Payable for the year ending December 31, 2020 was USD 513.00 M, a -5.35% change year over year.
StockViz
Competitors
Roche Holding AG
USD 317.50
RO.SW
-1.30
-0.41%
Thermo Fisher Scientific Inc.
USD 462.39
TMO
+1.67
0.36%
Becton, Dickinson and Company
USD 192.50
BDX
-1.00
-0.52%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Sartorius Stedim Biotech S.A.
USD 196.66
DIM.PA
+2.42
1.24%
bioMérieux S.A.
USD 144.74
BIM.PA
-0.44
-0.30%
United Therapeutics Corporation
USD 300.43
UTHR
-1.07
-0.36%
Medpace Holdings, Inc.
USD 449.77
MEDP
+15.42
3.55%
Revvity, Inc.
USD 85.80
RVTY
-1.04
-1.20%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Sysmex Corporation
USD 13.98
6869.T
+0.14
1.00%
Exact Sciences Corporation
USD 40.91
EXAS
-0.08
-0.19%
Bio-Techne Corporation
USD 50.15
TECH
-0.27
-0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.49
002294.SZ
-0.12
-1.80%
Guardant Health, Inc.
USD 54.80
GH
+0.57
1.05%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Roche Holding AG
USD 317.50
RO.SW
-1.30
-0.41%
Thermo Fisher Scientific Inc.
USD 462.39
TMO
+1.67
0.36%
Becton, Dickinson and Company
USD 192.50
BDX
-1.00
-0.52%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Sartorius Stedim Biotech S.A.
USD 196.66
DIM.PA
+2.42
1.24%
bioMérieux S.A.
USD 144.74
BIM.PA
-0.44
-0.30%
United Therapeutics Corporation
USD 300.43
UTHR
-1.07
-0.36%
Medpace Holdings, Inc.
USD 449.77
MEDP
+15.42
3.55%
Revvity, Inc.
USD 85.80
RVTY
-1.04
-1.20%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Sysmex Corporation
USD 13.98
6869.T
+0.14
1.00%
Exact Sciences Corporation
USD 40.91
EXAS
-0.08
-0.19%
Bio-Techne Corporation
USD 50.15
TECH
-0.27
-0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.49
002294.SZ
-0.12
-1.80%
Guardant Health, Inc.
USD 54.80
GH
+0.57
1.05%